About
Aligos Therapeutics is a clinical-stage biopharmaceutical company developing oral therapies that target chronic hepatitis B virus infection and liver fibrosis.
Explore Aligos Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.